Liuxi Chen

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 4

Top Topics

High Resolution Mass Spectrometry

Bioinformatics Analysis

Gas Chromatography

Top Venues

Biomedical chromatography : BMC

Chemical research in toxicology

Clinical and translational science

Genentech Inc

Texas A&M University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Genentech Inc Jun 27 2016

United States

Scientist :: DMPK

Waters Corp Oct 01 2014 - Apr 01 2016

United States

Senior Scientist :: Global Marketing

Education History

Texas A&M University - Aug 01 2012

United States

PHD :: Chemistry

Publications

Liuxi Chen, Yuxiang Cui, Brian Dean, Xiaorong Liang
Matrix effect in bioanalytical assay development using supercritical fluid chromatography-mass spectrometry. Biomedical chromatography : BMC (2023)
Yuxiang Cui, Kevin Kowalski, Michael Van Parys, Dennis Miller, Patricia Hansen, Xiaorong Liang, Brian Dean, Liuxi Chen
Impact assessment of metabolite instability in the development and validation of LC-MS/MS bioanalytical assays for measurement of rosuvastatin in human plasma and urine samples. Biomedical chromatography : BMC (2023)
Fei Tang, Rebecca Kunder, Tom Chu, Avis Hains, Allen Nguyen, Jacqueline M McBride, Yu Zhong, Sara Santagostino, Maria Wilson, Abigail Trenchak, Liuxi Chen, Justin Ly, Anita Moein, Nicholas Lewin-Koh, Vibha Raghavan, Uyi Osaghae, Chris Wynne, Ryan Owen, David E Place
First-in-human phase 1 trial evaluating safety, pharmacokinetics, and pharmacodynamics of NLRP3 inflammasome inhibitor, GDC-2394, in healthy volunteers. Clinical and translational science (2023)
Liuxi Chen, James Smith, Jaromir Mikl, Ryan Fryer, Frank Pack, Brad J Williams, Jonathan A Phillips, Vladimir V Papov
A Multiplatform Approach for the Discovery of Novel Drug-Induced Kidney Injury Biomarkers. Chemical research in toxicology 30 (10) (2017)